1. Academic Validation
  2. Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening

Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening

  • Eur J Med Chem. 2017 Mar 31:129:275-286. doi: 10.1016/j.ejmech.2017.02.020.
Taijin Wang 1 Zhuang Yang 1 Yongguang Zhang 1 Wei Yan 1 Fang Wang 1 Linhong He 1 Yuanyuan Zhou 1 Lijuan Chen 2
Affiliations

Affiliations

  • 1 State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • 2 State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu, 610041, China. Electronic address: chenlijuan125@163.com.
Abstract

The cyclin dependent kinase CDK8, along with Med12 and Med13, form the kinase module of the Mediator complex. CDK8 expression associates with the activation of β-catenin in colon and gastric cancers. Herein, we applied docking-based virtual screening (VS) using the multiple crystal structures to identify several potent CDK8 inhibitors. The appropriate use of multiple crystal structures obtained a better enrichment of CDK8 conformations to cope with the protein flexibility. Later on, the 2D similarity search was used to find the derivatives of the high inhibitory CDK8 inhibitors we discovered by VS. Finally, we measured the dose response behaviors, the IC50 values of compound W-34, W-37, W-8, WS-2 are 6.5 nM, 36 nM, 93 nM, 9 nM, respectively. These novel leads provided good starting points to design and synthesis a series of highly selective and potent CDK8 inhibitors.

Keywords

2D similarity search; CDK8 inhibitors; Cyclin C; Molecular docking; Virtual screen.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-169633
    CDK8抑制剂
    CDK